top of page
EXE-LOGO-MEDIXAL-BLANC.png

QUALITY / REACTIVITY / ADAPTABILITY / SIMPLICITY

​​MEDIXAL specializes in tailored solutions for pharmaceutical companies,

marketing authorization holder, ensuring seamless compliance

with strict French and European regulations.

​

As a licensed pharmaceutical operator (status of Etablissement pharmaceutique exploitant), we offer expertise in all fields to pharmaceutical companies looking for a partner to distribute their drugs on the French market.

​

We are the Coordinator of the entire post-clinical activities in France:

Market access, Exploitant, Compliance, Distribution, Warehousing & Logistic, Promotional

and non promotionnals activities with sales reps.

​

We are accountable for the responsibilities related to the distribution of pharmaceutical products in France.

​

MEDIXAL is committed to quality, innocuity and safety.

​

We simplify complexity, enabling you to focus on your business growth.

shutterstock_479711074.png

Why MEDIXAL

Unique official point of contact acting as local representative.

MEDIXAL staff has decades of experience with French regulations
in big pharma.

Unlike a large company, MEDIXAL is a company in its own right:

  - Agile

  - Reactive

MEDIXAL is a privileged partner of the Pharmafield group.

MEDIXAL adapts to the client in order to provide a tailor-made service in a very heavy regulatory context.

Choosing MEDIXAL is to offer simplicity in a complicated regulatory context enabling you to focus on your business growth.

CONTACT

US

Address

23 Boulevard Vital Bouhot

92200 NEUILLY SUR SEINE FRANCE

Email

Phone

+33 7 88 37 60 32

If you wish to report a product quality complaint, an adverse effect, or a medical information request related to a product distributed by Medixal, please send your request to:

Contact FRANCE

By submitting this form, I agree that the information entered will be used to contact me as part of the commercial relationship that may result from this request.

Thanks for submitting!

Site mis à jour en février 2025

Référence : MED-COM-2025-007

bottom of page